Asthma is under-recognized and undermanaged in the Malaysian university population: A comparison of findings from Malaysia against Singapore from the Singapore/Malaysia cross-sectional genetic epidemiology study [0.03%]
马来西亚大学校园人群哮喘的漏诊和管理不足：与新加坡研究结果对比分析
Qi Yi Ambrose Wong,Dingyu Cen,Jun Jie Lim et al.
Qi Yi Ambrose Wong et al.
Introduction: Asthma is a chronic respiratory disease characterized by chest tightness, coughing, shortness of breath, and wheezing. Results from the Global Burden of Diseases Study 2021 have shown that asthma poses a not...
Response to the comment regarding our article entitled "A 300 IR 5-grass pollen sublingual immunotherapy tablet-specific systematic review and meta-analysis confirms its clinical benefits for patients with allergic rhinoconjunctivitis with or without asthma" [0.03%]
关于我刊“舌下免疫治疗片A300IR（含五种草花粉）：系统性回顾与meta分析证实其对伴有或不伴哮喘的过敏性结膜炎患者的临床益处”一文的回复
Danilo Di Bona,Giorgio Walter Canonica
Danilo Di Bona
World Allergy Organization survey on the diagnosis and management trends of perioperative anaphylaxis [0.03%]
世界过敏组织关于围手术期过敏性休克诊断和管理趋势的调查研究
Alexei Gonzalez-Estrada,Ricardo J Estrada-Mendizabal,Ignacio J Ansotegui et al.
Alexei Gonzalez-Estrada et al.
Background: Perioperative anaphylaxis (POA) is a life-threatening condition with substantial variability in evaluation and management practices. Objective...
Indication for biologic treatment in a real-world cohort of chronic rhinosinusitis patients according to international recommendations: Evidence from the European CRS outcome registry (CHRINOSOR) [0.03%]
基于国际推荐的生物制剂治疗慢性鼻窦炎患者的真实世界队列研究证据：来自欧洲CRS结果登记处（CHRINOSOR）的数据
Sven F Seys,Josje J Otten,Joost de Kinderen et al.
Sven F Seys et al.
Background: In recent years, treatment options for patients with uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) have been expanded with biologics. Definitions of uncontrolled severe disease differ a...
Characterization and diagnostic evaluation of hypersensitivity to iodinated contrast media: A retrospective analysis [0.03%]
碘化对比媒体过敏的特征和诊断评价：回顾性分析
Gabija Brusokienė,Kotryna Linauskienė,Kęstutis Černiauskas et al.
Gabija Brusokienė et al.
Background: Hypersensitivity reactions to iodinated contrast media (ICM) pose a growing clinical challenge, especially for patients requiring imaging. Differentiation of immune-mediated hypersensitivity from non-immune ad...
Corrigendum to "Evaluating vaccination dosing strategies for SARS-CoV-2 in patients at high-risk for allergic reactions: Insights from vaccination campaign" [World Allergy Organ J 18(8) (2025 Jul 28) 101095. doi: 10.1016/j.waojou.2025.101095] [0.03%]
关于“评估SARS-CoV-2疫苗接种剂量策略在过敏反应高危患者中的效果：来自疫苗接种工作的见解”的勘误修正公告 [World Allergy Organ J 18(8) (2025 Jul 28) 101095. doi: 10.1016/j.waojou.2025.101095]
Stefania Nicola,Iuliana Badiu,Nicolò Rashidy et al.
Stefania Nicola et al.
[This corrects the article DOI: 10.1016/j.waojou.2025.101095.]. © 2026 The Author(s).
Comment on "IFITM1 is required for epithelial mesenchymal transition in airway remodeling of allergic asthma" [0.03%]
关于“IFITM1在过敏性哮喘气道重塑上皮间质转化中是必需的”的评论
Sangameshwar Manikya,Varshini Vadhithala,Rajnish Kumar et al.
Sangameshwar Manikya et al.
Anaphylaxis events in the PIONEER study of avapritinib in indolent systemic mastocytosis [0.03%]
PIONEER研究中阿伐普替尼治疗惰性系统性肥大细胞增多症的过敏事件
Thanai Pongdee,Mariana Castells,Cem Akin et al.
Thanai Pongdee et al.
Background: Patients with indolent systemic mastocytosis (ISM), a clonal mast cell disease primarily driven by the KIT D816V mutation, often have lifelong debilitating symptoms. Anaphylaxis is a common feature of the dise...
Overview of allergic disease: Anaphylaxis - WAO White Book on Allergy 2026 - 2.11 [0.03%]
过敏性疾病概览：过敏性休克-2026年WAO过敏白皮书第2.11章
Victoria Cardona
Victoria Cardona
Anaphylaxis is a rapid-onset, potentially fatal systemic hypersensitivity reaction marked by airway, breathing, or circulatory compromise, which may occur even without skin symptoms. It is driven primarily by mast-cell activation-usually th...
What is new on the horizon for the biologics world: New kids of the block - WAO state of art [0.03%]
生物制剂的新生力量：展望与挑战
Giorgio Walter Canonica,José Antonio Ortega-Martell,Rosalaura V Villarreal-González et al.
Giorgio Walter Canonica et al.
Background: Advances in the understanding of type 2 inflammation have driven the development of novel biologics and small molecules for allergic diseases. New therapies targeting cytokines, receptors, and intracellular pa...